相关实验视频
Updated: Jun 1, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
血管生成的分子机制和临床应用
Peter Carmeliet1, Rakesh K Jain
1Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB, Leuven B-3000, Belgium. peter.carmeliet@vib-kuleuven.be
新的研究探索了新的分子标,以改善癌症的抗血管生成疗法. 了解血管生长 (血管生成) 是克服治疗耐药性和增强患者益处的关键.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 心血管研究的心血管研究.
背景情况:
- 血管提供氧气和营养物质,但也为癌症等疾病提供燃料.
- 了解血管新生学的重大进展导致了抗血管新生药物.
- 血管内皮生长因子 (VEGF) 阻断剂对许多患者有益,但面临着耐药性和有效性等局限性.
研究的目的:
- 探索抗血管生成疗法的新型分子标.
- 确定改善治疗效益的新原则.
- 为了解决当前抗血管生成策略的局限性.
主要方法:
- 审查最近的临床前研究.
- 对临床试验数据的分析.
- 研究血管生成中的分子机制.
主要成果:
- 识别VEGF以外的新分子标.
- 控制血管生成的新兴原则.
- 支持改善治疗策略的证据.
结论:
- 新的分子标和原理为增强抗血管生成疗法提供了有希望的途径.
- 克服耐药性和提高疗效是未来治疗的关键目标.
- 需要进一步的研究来将这些发现转化为改善患者的治疗结果.
更多相关视频
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
09:16Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay
Published on: May 31, 2024
相关概念视频
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Overview of Cell-Matrix Interactions
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Non-Canonical Wnt Signaling Pathways